Yang Wang1,2, Ying Xie1, Yiyi Ye1, Youyang Shi1, Feifei Li1, Mengdie Zhu1, Ciyi Hua1, Yuan Xu1, Rui Yang1,3,*, Sheng Liu1,4,*
Oncology Research, Vol.34, No.7, 2026, DOI:10.32604/or.2026.078051
- 16 June 2026
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast malignancy characterized by poor clinical outcomes and limited therapeutic options. The identification of reliable biomarkers for predicting prognosis and immunotherapeutic response remains an urgent clinical need. This study aimed to develop an integrative lactylation-related gene signature to simultaneously evaluate prognostic trajectories and immunotherapeutic sensitivity in TNBC. Methods Transcriptomic and clinical data from public TNBC cohorts were systematically analyzed. Lactylation-related gene signatures were used to stratify patients via consensus clustering. A scoring model was constructed based on differentially expressed genes between clusters, and its associations with… More >